Institutional belief · Cancer surgery and treatment standards
Radical mastectomy as the best route to breast-cancer survival
The most extensive routine removal of the breast, axillary lymph nodes and chest muscles was treated as giving women with operable breast cancer the best chance of survival because the disease was expected to spread outward in an orderly local-to-regional sequence.
1 episode
Current understanding
Current understanding
For many patients with early breast cancer, more extensive local surgery does not improve overall survival. Randomized trials showed no survival advantage for Halsted radical mastectomy over less extensive surgery, and breast-conserving surgery followed by radiation can provide survival comparable to mastectomy for appropriately selected patients.
Consequences and human impact
Consequences and human impact
Halsted radical mastectomy became the dominant U.S. breast-cancer operation for much of the twentieth century. Its local-control logic exposed generations of women to removal of the chest muscles and extensive lymphatic tissue, with substantial disfigurement, arm swelling and functional impairment, before randomized trials showed that greater surgical extent did not improve survival.
How the consequences followed
Radical mastectomy was an important advance over earlier surgery because it greatly improved local control at a time when anesthesia, antisepsis and cancer surgery were rapidly developing.
The correction does not mean mastectomy itself is obsolete. Mastectomy remains appropriate in many circumstances; what failed was the rule that routinely removing more local tissue necessarily improved survival.
Quantitative figures are highlighted only when the cited evidence supports them. The scale of a related catastrophe is not automatically treated as a death toll caused solely by this belief.
Institutional episode
United States
Halsted's Johns Hopkins operation converted a coherent theory of orderly cancer spread into a durable surgical standard. If breast cancer moved outward through contiguous tissues and lymph nodes, the safest operation seemed to be the widest possible en-bloc removal. Radical mastectomy dominated U.S. treatment for decades despite its substantial physical costs. The NSABP B-04 trial, begun in 1971 and reported in 1977, found that women receiving the radical operation did not live longer than women treated with less extensive surgery. European breast-conservation trials and later U.S. trials reinforced the same lesson, replacing routine maximal surgery with treatment tailored to disease extent and biology.
Institutions
- The Johns Hopkins Hospital
- American surgical profession
Documented consequences
- Radical mastectomy became the prevailing operation for breast cancer in the United States for much of the twentieth century
- Women routinely lost the breast, axillary lymph nodes and chest muscles even when less extensive surgery would later prove equally effective for survival
- The operation could leave major disfigurement, lymphedema, pain, weakness and restricted arm movement
- Randomized trials beginning in the 1970s found that less extensive surgery did not reduce survival, forcing a major change in surgical standards
Institutional machinery
William Halsted developed and reported his radical mastectomy while serving as surgeon-in-chief at The Johns Hopkins Hospital. The operation removed the breast, axillary lymph nodes and pectoral muscles in one block, reflecting the model that breast cancer spread progressively through adjacent tissues and regional lymphatics. The procedure became the prevailing U.S. standard for decades; by the 1970s, surgeons who proposed less extensive operations could still be accused of offering inadequate treatment.
Sources and what they establish
- Bernard Fisher, M.D. — Breast Cancer SurgeryU.S. National Cancer Institute
- Umberto Veronesi, M.D.U.S. National Cancer Institute
Describes radical mastectomy as the prevailing standard before the first European randomized breast-conservation trials and states that later U.S. trials confirmed no survival advantage for radical surgery in early-stage disease.
- The Halsted mastectomy: present illness and past historyWestern Journal of Medicine / PubMed Central
Last reviewed: 27/08/2026